We found that 21% (15 of 85) of COVID-19 patients had IgM ALAb at the time of diagnosis, while none were found in either HD- or influenza (flu)-challenged and infected individuals (24) (Figures 1A, C). This evidence concerns the gene CD40LG and COVID-19.